miR-25 and miR-92b regulate insulin biosynthesis and pancreatic β-cell apoptosis
Author:
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s12020-022-03016-9.pdf
Reference33 articles.
1. D.L. Eizirik, L. Pasquali, M. Cnop, Pancreatic beta-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat. Rev. Endocrinol. 16, 349–362 (2020).
2. J. Rodriguez-Comas et al. Stress-induced microRNA-708 impairs beta-cell function and growth. Diabetes 66, 3029–3040 (2017).
3. Q. Huang et al. Glucolipotoxicity-inhibited miR-299-5p regulates pancreatic beta-cell function and survival. Diabetes 67, 2280–2292 (2018).
4. Y.S. Oh, Mechanistic insights into pancreatic beta-cell mass regulation by glucose and free fatty acids. Anat. Cell Biol. 48(1), 16–24 (2015).
5. M.S. Remedi, C. Emfinger, Pancreatic β-cell identity in diabetes. Diabetes Obes. Metab. 18, 110–116 (2016).
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Interplay Between Cytokines and MicroRNAs to Regulate Metabolic Disorders;Journal of Interferon & Cytokine Research;2024-08-01
2. Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment;Current Issues in Molecular Biology;2024-07-18
3. The role of retroelements of the human genome in the development of type 1 diabetes mellitus;Kazan medical journal;2024-06-03
4. MicroRNAs in chronic pediatric diseases (Review);Experimental and Therapeutic Medicine;2024-01-15
5. MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view;ESMO Open;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3